Overall safety of relamorelin in adults with diabetic gastroparesis: Analysis of phase 2a and 2b trial data

BACKGROUND: Relamorelin, a pentapeptide ghrelin receptor agonist, accelerated gastric emptying significantly and improved symptoms in adults with diabetic gastroparesis in phase 2 trials. AIM: To assess the safety and tolerability of relamorelin across phase 2 trials. METHODS: Safety assessments in...

Descripción completa

Detalles Bibliográficos
Autores principales: Camilleri, Michael, Lembo, Anthony, McCallum, Richard, Tourkodimitris, Stavros, Kemps, Lara, Miller, Matthew B., Bertelsen, Kirk, Iacob, Alexandru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Safety of Relamoralin in Diabetic Gastroparesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318559/
https://www.ncbi.nlm.nih.gov/pubmed/32301137
http://dx.doi.org/10.1111/apt.15711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318559/
https://www.ncbi.nlm.nih.gov/pubmed/32301137
http://dx.doi.org/10.1111/apt.15711

Ejemplares similares